Related Experiment Video
Updated: Apr 8, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Ghrelin Levels in Patients With Primary Open-Angle Glaucoma
Asaad A Ghanem1, Salah E Mady, Tarek N Attia
1From the *Mansoura Ophthalmic Center, Faculty of Medicine, Mansoura University, Mansoura, Daqahlia; †Ophthalmology Department, Faculty of Medicine, Banha University, Banha, Qalyubia; and ‡Department of Medical Biochemistry, Faculty of Medicine, Mansoura University, Mansoura, Daqahlia, Egypt.
Purpose:
This study was aimed to assess the levels of ghrelin in aqueous humor and plasma of human eyes with primary open-angle glaucoma (POAG) and to correlate their concentrations with the severity of glaucoma.
Design:
This was a case-control, prospective study.
Methods:
Fifty patients with POAG and 35 patients with senile nonpathologic cataract (control group) were enrolled in the study prospectively. Aqueous humor samples were obtained by paracentesis from patients with glaucoma and cataract who underwent elective surgery. Aqueous humor and corresponding plasma samples were analyzed for ghrelin concentrations by radioimmunoassay diagnostic kits assay.
Results:
Ghrelin levels were significantly lower in aqueous humor of patients with POAG with respect to the comparative group of patients with cataract (P < 0.001). There was no significant difference in the levels of ghrelin in the plasma of patients with POAG and that of patients with cataract. A positive correlation was found between plasma/aqueous humor ghrelin concentration in patients with POAG versus the control group (P < 0.001). No significant correlation was found between the levels of ghrelin and the severity of visual field loss.
Conclusions:
Lower levels of aqueous humor ghrelin may be associated with POAG and may be a consequence of glaucomatous damage.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Hypoglycemia and Glucagon

